- March 1, 2021Read more
The latest issue of ‘Pharmaceutical Post’ is highlighted diabetes device portfolio and the evolution
- February 26, 2021Read more
The Gender Equality Index 2020 has well improved. As of 2019, Nemera shared its overall ambitions with its staff concerning gender parity for 2022, and has committed to equality in terms of employment, professional development and promotions for all its employees.
- February 19, 2021Read more
The latest issue of ‘EPM’ is highlighted Safe’n’Spray, the smart device that can help manage drug overdosing
- January 26, 2021Read more
The latest issue of ‘Skin Drug Delivery’ is highlighted Nemera’s holistic approach in dermal pharmaceutical application.
- January 20, 2021Read more
This article presents the so called Between-Batch Bioequivalence (BBE) method, evaluated through both simulation and real-case (Nasonex® & Flonase®) studies.